MSB 7.69% $1.19 mesoblast limited

agree, stopping the trial early and risking the FDA refusing on...

  1. 100 Posts.
    lightbulb Created with Sketch. 10
    agree, stopping the trial early and risking the FDA refusing on excuses like insufficient data would be silly. I hate to wait any longer but it is what it is.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.